Identifying the need for new drugs – Opening doors

20 Mar 2017

Paul Willis, Benoit Laleu and Jaya Banerji

European Biopharmaceutical Review
Following the adoption of the 2030 Agenda for Sustainable Development by world leaders, the pharma industry has seen an increased emphasis on collaboration and openness in the drug discovery process. The Malaria and Pathogen Boxes especially demonstrate the benefits of open source approaches.
This article is taken from European Biopharmaceutical Review April 2017, pages 64-68. © Samedan Ltd.